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The regulatory system of smooth muscle thin filaments is thought to involve a major calcium-cahnodulin and actin binding protein: caldesmon. 
A dissective approach was used to isolate a 35 kDa C-terminal fragment of the molecule and to produce antibodies reacting against both the intact 
and the 15 kDa N-terminal end of this parental fragment. While this purified 15 kDa caldesmon fragment demonstrates a weak actin association, 
we observed that it cross-links actin filaments into loose bundles. These structures were labelled with a selective antibody and showed regular period- 
ic striation with repeats of approximately 40 nm. This work brings additional information to previous reports using an actin and cahnodulin binding 
25 kDa C-terminal fragment of the caldesmon molecule [(1989) J. Biol. Chem. 264,2869-28751. We demonstrate that a purified fragment corre- 
sponding to a sequence smaller than 96 amino acids, which contains no cystein residue, is able to interact with actin at a single site which is not 
the calmodulin modulated. 
Immuno-electron microscopy; Actin; Caldesmon 
1. INTRODUCTION 
Caldesmon, found recently in smooth [l], cor- 
responds to a major protein involved in control of the 
actomyosin interaction. Further characterization show- 
ed that this protein interacts with actin and calmodulin 
and also with tropomyosin and myosin. The myosin 
binding site is located in the N-terminal part of the 
molecule [2], the actin and calmodulin binding sites [3] 
and the tropomyosin binding region [4] are confined to 
its C-terminal end. This has been carefully reported, 
with the help of the C-DNA deduced amino-acid se- 
quence, in a tentative map of the major binding do- 
mains of caldesmon [5]. Antibodies have already been 
used as specific antagonists to investigate the 
caldesmon role in the thin filament regulation [6,7]. In 
this study, we observed by electron microscopy the 
complexes actin-caldesmon and actin- 15 kDa fragment 
of caldesmon. We used specific antibody to selectively 
label the induced actin filament aggregation. The 
results presented here enabled us to propose an ex- 
planation for the bundling properties of caldesmon on 
actin filaments as being an induced conformational 
change rather than an oxidation process of the 
molecule. 
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2. MATERIALS AND METHODS 
2.1. Protein preparations 
Turkey gizzard smooth muscle caldesmon and specific fragments 
were obtained from fresh material following the previously described 
procedure [8]. Skeletal F-actin was obtained according to Eisenberg 
and Kielly [9]. Extinction coefficients were 280 nm, 11.0 for F-actin 
[lo] and caldesmon or purified caldesmon fragment concentrations 
were determined by Lowry assay using bovine serum albumin as 
standard [ 111. 
2.2. Immunization procedure 
Two rabbits were immunized using multiple injections (2 mg/injec- 
tion) of 35 kDa caldesmon fragment emulsified in Freund’s complete 
adjuvant and standard immunization protocols. The specificity of 
our antibodies was assessed by Western immunoblotting. 
2.3. Electron microscopic conditions 
Electron microscopy was performed using negative staining as 
previously described [l 11. Two different procedures were used for an- 
tibody labelling: (i) The caldesmon and antibody complex was ob- 
tained by preincubation for 10 min (0.3 mM CaD and diluted 
antiserum l/250), then mixed with F-actin at a caldesmon/actin 
molar ratio of l/7. (ii) antibody was added to the actin-caldesmon 
complex in the same dilution and incubated 15 min before electron 
microscopy processing. The same procedures were followed when a 
15 kDa caldesmon fragment was used instead of native caldesmon. 
3. RESULTS 
As shown in Fig. 1, the immunoblot of the protein 
bands is strongly positive for each isolated species. 
Thus we have produced an antibody that selectively 
recognizes native caldesmon by its C-terminal end, 
either as 35 kDa or as 15 kDa segments. The antiserum 
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Fig. 1. Immunoblot of SDS analysis of purified native caldesmon and caldesmon fragments. Proteins purified samples are: lane 1, native 
caldesmon; lane 2,35 kDa C-terminal thrombic fragment; lane 3, 15 kDa submaxillaris-fragment. (A) Coomassie Blue staining. (B) Corresponding 
immunoblot shown by 35 kDa antiserum diluted 1000 times. Note: The pattern in lane 2 shows some breakdown products. 
Fig. 2. Ultrastructural study: F-actin was incubated for 10 min with native caldesmon (A) or with 15 kDa fragment (B). Bar: 0.25 pm. 
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Fig. 3. Electron micrographs of the complex of actin + 15 kDa 
caldesmon + antibody. Alternative striation is indicated by black ar- 
rows and are clearly visible in A and B. Note: Loose bundles in- 
creased upon longer incubation times but are always different and 
less packed than those obtained with native caldesmon. Bar: 0.25am. 
did not recognize actin or the 90 kDa N-terminal part 
of caldesmon. 
We compared in the same 7/l actin/~aldesmon ratio 
for each experiment, electron microscopic images 
(Fig. 2) of actin mixed with native caldesmon (A), 15 
kDa fragments (B). 
When native caldesmon was mixed with F-a&in, 
large bundles were induced and a few free F-actin 
filaments were present. Longitudin~ associations of 
twisted F-actin were tightened in these structures, so 
filaments could not be counted. (Similar structures 
were obtained with 35 kDa fragment [1X] .) 
On the contrary, observed negative staining of the 15 
kDa caldesmon fragment and actin association gave 
rise to large bundles with networks of weak twisted 
filaments. These structures formed an irregular wide 
net, as shown in Fig. 2B, in which lateral associations 
of loosely packed actin filaments were easily counted. 
These structures were then observed, with the help of 
35 kDa antibody, at higher magnification allowing us 
to localize caldesmon or caldesmon fragments in the ac- 
tin induced bundles. 
Caldesmon is located (Fig. 3) along the actin fila- 
ments with a periodicity of 37 nm. However, the images 
obtained with 15 kDa fragment enabled us to show on 
looser, less packed and straight bundles, clearer cross- 
striation patterns of these structures. The two ex- 
perimental procedures used for the complex formation 
induced similar structures, indicating that this selective 
antibody does not prevent or weaken the actin-caldes- 
mon interface. 
4. DISCUSSION 
In this investigation, attempts were made to deter- 
mine whether caldesmon oxidation is needed to assem- 
ble F-actin filaments into bundles. To accomplish this, 
turkey gizzard caldesmon was proteolytically cleaved. 
We have specifically produced a 15 kDa fragment 
which recognized actin, and we have controlled by se- 
quencing that no cysteine residue was present in its 
amino acid sequence. 
We demonstrated that the 15 kDa fragment contains 
an actin binding region inducing weak links between ac- 
tin filaments, rather than compact aggregations of tight 
bundles. 
Addition~ly, we observed a striation within the actin 
bundles with a periodicity of 37 to 40 nm when labelled 
by the specific 35 kDa antibody, in complete agreement 
with recent results [13-141. In comparison with 
chymotryptic 40 kDa fragment, the thrombic 35 kDa 
C-terminal domain is shortened by 32 residues in its N- 
terminal extremity [5], thus we can conclude that this 
shortening does not alter the antigenicity of the produc- 
ed antibody. Riseman et al. [14] used a 25 kDa C- 
terminal end of the parental 40 kDa chymotryptic frag- 
ment and they were surprised to observe that it con- 
trasted with the reduced intact molecule, cross-links of 
F-actin into tightly ordered bundles. Here we demon- 
strate that a fragment as small as our 15 kDa fragment, 
the N-terminal end of the parental 35 kDa thrombic 
fragment (see Fig. 3), is also able to produce loosely 
ordered bundles which thickened upon incubation. 
This result shows the presence of two kinds of actin 
binding sites within caldesmon. We propose that this 
peptide of 96 amino acids (without cysteine residue) 
must induce a conformational change in the actin 
filaments, increasing their ability to aggregate. 
However, this interaction could not be dependent on 
calmodulin switching, since this fragment does not con- 
tain any calmodulin binding site [S]. 
We conclude that caldesmon bundle formation in- 
volves different interaction sites with actin, at least two 
or more according to the last report of Wang et al. [l5]. 
This effect on actin assembly and the possible existence 
of weak and strong forms of actin-~~desmon complex 
is in agreement with recent proposals of Galazkiewicz 
et al. [16]. This is presently investigated with the 
regulatory function of caldesmon being carried out on 
the acto-myosin complex. 
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